1. Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020; 20(2):124–127. PMID:
32139372.
2. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMID:
32081636.
4. Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus (COVID-19) cases - statistics and research - our world in data. Updated 2020. Accessed 2020 May 8.
https://ourworldindata.org/covid-cases.
7. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. J Clin Med. 2020; 9(4):941.
8. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Wkly. 2020; 2(8):113–122.
9. European Center for Disease Prevention and Control. Coronavirus Disease 2019 (COVID-19) Pandemic: Increased Transmission in the EU/EEA and the UK: Seventh Update. Solna: European Center for Disease Prevention and Control;2020.
10. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020; 63(3):364–374. PMID:
32048163.
12. Yen MY, Schwartz J, Chen SY, King CC, Yang GY, Hsueh PR. Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts. J Microbiol Immunol Infect. 2020; 53(3):377–380. PMID:
32205090.
13. Xu B, Gutierrez B, Mekaru S, Sewalk K, Goodwin L, Loskill A, et al. Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data. 2020; 7(1):106. PMID:
32210236.
14. National Center of Public Health. Kazakhstan. Accessed 2020 May 8.
https://hls.kz/.
15. Republican Center for Healthcare Development of the Ministry of Health of the Republic of Kazakhstan. Accessed 2020 May 8.
http://www.rcrz.kz/index.php/en/.
17. Gromova O, Doschanova A, Lokshin V, Tuletova A, Grebennikova G, Daniyarova L, et al. Vitamin D deficiency in Kazakhstan: cross-sectional study. J Steroid Biochem Mol Biol. 2020; 199:105565. PMID:
31812522.
19. Rachah A, Torres DF. Analysis, simulation and optimal control of a seir model for ebola virus with demographic effects. Communications. 2018; 67(1):179–197.
21. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020; 55(6):105948. PMID:
32201353.
22. Peng L, Yang W, Zhang D, Zhuge C, Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling. Updated 2020. Accessed 2020 May 8.
http://arxiv.org/abs/2002.06563.
23. Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat Med. 2020; 1–6. PMID:
31932805.
24. Coomes EA, Leis JA, Gold WL. Quarantine. CMAJ. 2020; 192(13):E338. PMID:
32198177.
26. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395(10227):912–920. PMID:
32112714.
27. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020; 382(12):1177–1179. PMID:
32074444.
28. Chatterjee K, Chatterjee K, Kumar A, Shankar S. Healthcare impact of COVID-19 epidemic in India: a stochastic mathematical model. Med J Armed Forces India. 2020; 76(2):147–155.
29. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46:846–848. PMID:
32125452.
30. Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, et al. Cytokine release syndrome. J Immunother Cancer. 2018; 6(1):56. PMID:
29907163.
31. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; 39(5):405–407. PMID:
32362390.
32. Dauletyarova MA, Semenova YM, Kaylubaeva G, Manabaeva GK, Toktabayeva B, Zhelpakova MS, et al. Are Kazakhstani women satisfied with antenatal care? Implementing the WHO tool to assess the quality of antenatal services. Int J Environ Res Public Health. 2018; 15(2):325.
33. Dauletyarova M, Semenova Y, Kaylubaeva G, Manabaeva G, Khismetova Z, Akilzhanova Z, et al. Are women of East Kazakhstan satisfied with the quality of maternity care? Implementing the WHO tool to assess the quality of hospital services. Iran J Public Health. 2016; 45(6):729–738. PMID:
27648415.